  With the maturation of metabolomics science and proliferation of biobanks,
clinical metabolic profiling is an increasingly opportunistic frontier for
advancing translational clinical research. Automated Machine Learning (AutoML)
approaches provide exciting opportunity to guide feature selection in agnostic
metabolic profiling endeavors, where potentially thousands of independent data
points must be evaluated. In previous research, AutoML using high-dimensional
data of varying types has been demonstrably robust, outperforming traditional
approaches. However, considerations for application in clinical metabolic
profiling remain to be evaluated. Particularly, regarding the robustness of
AutoML to identify and adjust for common clinical confounders. In this study,
we present a focused case study regarding AutoML considerations for using the
Tree-Based Optimization Tool (TPOT) in metabolic profiling of exposure to
metformin in a biobank cohort. First, we propose a tandem rank-accuracy measure
to guide agnostic feature selection and corresponding threshold determination
in clinical metabolic profiling endeavors. Second, while AutoML, using default
parameters, demonstrated potential to lack sensitivity to low-effect
confounding clinical covariates, we demonstrated residual training and
adjustment of metabolite features as an easily applicable approach to ensure
AutoML adjustment for potential confounding characteristics. Finally, we
present increased homocysteine with long-term exposure to metformin as a
potentially novel, non-replicated metabolite association suggested by TPOT; an
association not identified in parallel clinical metabolic profiling endeavors.
While considerations are recommended, including adjustment approaches for
clinical confounders, AutoML presents an exciting tool to enhance clinical
metabolic profiling and advance translational research endeavors.
